UAT Group Subsidiary, The Dreaming Company Announces Hygieia Eye Gel
02 août 2022 08h30 HE
|
Umbra Applied Technologies Group, Inc.
Tampa, FL, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc. (OTC Pink UATG) ("UAT Group") announced today that its subsidiary, The Dreaming Company, is expanding on its...
UAT Group Subsidiary, The Dreaming Company Announces Hygieia Bedding Line
26 juil. 2022 08h00 HE
|
Umbra Applied Technologies Group, Inc.
Tampa, FL, July 26, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc’s (OTC Pink: UATG) ("UAT Group"), announced today that its subsidiary, The Dreaming Company, is expanding on the...
Institute of Biomedical Research Corp Announces Purchase of Biomedical and Nutraceutical Assets
22 juil. 2022 06h00 HE
|
Institute of Biomedical Research Corp.
SEATTLE, WA, July 22, 2022 (GLOBE NEWSWIRE) -- Institute of Biomedical Research Corp. (OTC Pink: MRES), a diversified biomedical company, announces the purchase of biomedical and nutraceutical...
By 2028, Demand for Electrophysiology Market Size $14.84 Billion at 10.2% CAGR Lead by Atrial Fibrillation (11% CAGR in 2028) Global Analysis by The Insight Partners
20 juin 2022 07h01 HE
|
The Insight Partners
New York, June 20, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Electrophysiology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
NeuroSigma Announces That a Team Led by UCLA Researchers Receives NIH Grant to Conduct a Multicenter Trial of eTNS for Pediatric ADHD
14 juin 2022 11h00 HE
|
NeuroSigma, Inc.
Double-blind randomized controlled trial will enroll up to 225 children at UCLA and Seattle Children’s Hospital NeuroSigma will provide Monarch eTNS Systems and funding for long-term follow-up ...
SPO Global Inc. Discusses Company’s Medical Devices
08 juin 2022 09h00 HE
|
SPO Global Inc.
Shandong, China, June 08, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today provides an in depth discussion of the company’s medical devices. ...
SPO Global Inc. Issues Letter to Shareholders
10 mai 2022 09h27 HE
|
SPO Global Inc.
Shandong, China, May 10, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today provides a corporate update and letter from CEO Fengyou Lu. Dear...
Edmund Optics® Expands in Response to Rapid Growth
28 avr. 2022 09h00 HE
|
Edmund Optics (edmundoptics.com)
BARRINGTON, N.J., April 28, 2022 (GLOBE NEWSWIRE) -- Edmund Optics®, a leading global manufacturer and supplier of optical components, has announced the opening of a new facility in Cherry Hill, NJ,...
NeuroSigma Announces King’s College London Team Receives MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD to Date
07 avr. 2022 11h00 HE
|
NeuroSigma, Inc.
Double-blind randomized controlled trial of eTNS for pediatric ADHD will enroll up to 150 participants at two sites in London and Southampton NeuroSigma’s Monarch eTNS System and electric patches to...
SPO Global Inc. Announces Partnership Between Cinuo Traditional Chinese Medicine, Science and Technology Group Co., Ltd and Spun SPO Medical (Group), a subsidiary of Gerbang Medical
29 mars 2022 09h00 HE
|
SPO Global Inc.
Shandong, China, March 29, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today announced a partnership Between Cinuo Traditional Chinese Medicine,...